Akari Therapeutics plc ADR (0.01 USD) AKTX
$8.70
-6.45%
at last close
Financials (TTM)
- Revenue
- —
- Net Income
- $-17,298,000
- Net Margin
- —
- Return on Equity
- -61.06%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 0.54
- Price / Sales
- —
Over the trailing twelve months, Akari Therapeutics plc ADR (0.01 USD) generated revenue of — and net income of $-17,298,000.
Key Stats
- Last Close
- $8.70
- Market Cap
- $15.23 million
- 52-Week Range
- $3.02 – $49.60
- Average Volume
- 83K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.